Sentry BioPharma Services ApS: Financial statements 2021
CVR: 41330619
Source: annual report 2021, Danish Business Authority
01/01/2021 – 31/12/2021
Sentry BioPharma Services ApS (CVR 41330619) has filed annual accounts for 2021. In 2021, the company reported a net result of DKK -1,055,832. Equity in the 2021 report amounted to DKK -1,378,104.
- Profit/Loss
- DKK -1,055,832
- Equity
- DKK -1,378,104
- Total Assets
- DKK 3,079,047
Official annual report
Find more companies like Sentry BioPharma Services ApS
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2021
Sentry BioPharma Services ApS has published its interim report for the period April 27, 2020 – December 31, 2020.
About Sentry BioPharma Services ApS
Sentry BioPharma Services ApS is a Danish company of the type Anpartsselskab based in København K, founded in 2020. The company is registered under the industry Oplagring og opbevaring. The management consists of Timothy Jon Mitchell and William Maxwell Tuttle. The company is owned by Sentry BioPharma Services, Inc.. The company has 1 employee (2026). In 2025, the company reported a net result of DKK -537,511 compared with DKK -3,275,518 the year before. Equity in the 2025 report amounted to DKK -11,627,396.